Saturday, February 18, 2006


Hepatitis C Combination Therapy - Hepatitis C Top Articles


Hepatitis C Top Articles
Chronic hepatitis C virus (HCV) infection affects approximately 3 million people in ... Is HCV Viral Load a Predictor of Progression of Chronic Hepatitis C? ...

HIV and HCV - Liver Health Information - The American Liver Foundation
HCV stands for the hepatitis C virus. It is the virus that causes hepatitis C. ... If you have HIV/HCV co-infection, then you have both HIV and HCV. ...

HCV Forum with Dr. Ben Cecil
Welcome to the HCV forum. I have been interested in treating patients with HCV for five years and have treated more than 1800 patients with antiviral ...

Hepatitis C Combination Therapy - HEPATITIS C INFO CENTER - With Daily Hepatitis C Updates


HEPATITIS C INFO CENTER - With Daily Hepatitis C Updates
Find all the Hepatitis C information you are looking for, over 2500 pages, INCLUDING THE LATEST NEWS about infection, symptoms and treatment...

WHO | Fact sheets
Hepatitis C · Hepatitis E · HIV/AIDS: "3 by 5" progress · Human genetics and noncommunicable disease · Human rights, women and HIV/AIDS. Back to top ...

Hepatitis C
NEW: The Hepatitis C Sourcebook. By Howard J. Worman, MD. The Hepatitis C Virus (HCV). HCV was discovered in 1989 by investigators at Chiron, Inc. Portions ...

HEPATITIS C PATIENT INFO - What You MUST Know...
Find answers to your most pressing questions. Award winning site developed by a patient to help you learn the facts...

Friday, February 17, 2006


Hepatitis C Combination Therapy - VX-950 To Get Fast Tracked


VX-950 To Get Fast Tracked
As you may recall we've been saying VX-950 is the revolutionary new therapy to watch for HCV. Now it looks like the FDA agrees this treatment is quite promising and deserving of faster approval than a lesser worthy approach. Another...

Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Viral Hepatitis
Title: Viral HepatitisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/5/2005

Hepatitis C Combination Therapy - Third Wave settles with Belgian firm


Third Wave settles with Belgian firm
bizjournals.com via Yahoo! Finance - Feb 09 1:08 PM
Third Wave Technologies Inc. will be allowed to sell hepatitis C analysis products in the United States under a patent litigation settlement with a Belgian firm.Save to My Web

Most common hepatitis C virus grown in lab
Galveston County Daily News - Feb 06 10:27 PM
GALVESTON Researchers at the University of Texas Medical Branch at Galveston have successfully grown the most common and damaging form of the hepatitis C virus in human liver cell cultures.Save to My Web

MedMira Announces Second Quarter Results
[Press Release] PR Newswire via Yahoo! Finance - Feb 16 1:15 PM
MedMira Inc. the global market leader in premium rapid diagnostic solutions, today announced its financial results for the three and six month periods ending January 31, 2006. Product sales in the second quarter were $1.1 million, compared to $768 thousand in the same quarter last year, an increase of 47%.Save to My Web

Jihad training debated at terror trial
The Monterey County Herald - Feb 17 12:09 PM
Vastly different pictures emerged Thursday of a man charged with attending an al-Qaida camp in Pakistan, with government attorneys portraying Hamid Hayat as a trained terrorist intent on attacking Americans while his defense described him as a directionless young man prone to wild storytelling.Save to My Web

Hepatitis C Combination Therapy - Positive Nation Health Feature - treatment/lifestyle section


Positive Nation Health Feature - treatment/lifestyle section
Hep C virus Hepatitis C combination therapy. During this time a drug called ribavirin, which had been shown in 1972 to possess broad antiviral activity ...

Roche - Investor Update - Landmark study published in New England ...
... Journal of Medicine shows 40 percent of people infected with HIV and hepatitis C had sustained response to Pegasys hepatitis C combination therapy.

NEW STUDY OF PEGASYS COPEGUS FOR HEP C LIVER TRANSPLANT PATIENTS
“There are many questions to be answered such as how safe and effective is hepatitis C combination therapy for patients who have received a liver transplant ...

Thursday, February 16, 2006


Hepatitis C Combination Therapy - Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C


Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Feb 15 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing in its initial Phase l clinical trial for Tarvacin Anti-Viral in the treatment of chronic hepatitis C virus infection .Save to My Web

Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program
[Press Release] PR Newswire via Yahoo! Finance - Jan 18 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical-stage product candidates for viral diseases and cancer, today announced that it has accelerated its clinical program for Tarvacin Anti-Viral for the treatment of chronic hepatitis C virus infection .Save to My Web

Hepatitis C Combination Therapy - No hepatitis in county from piercing, DHEC says


No hepatitis in county from piercing, DHEC says
The Times and Democrat, SC - Feb 8, 2006Not one single case of hepatitis C related to body piercing has been found in Orangeburg County, a spokesperson for the state Department of Health and ...

HGLHC to hold women s health screening
Bay Windows, MA - 3 hours ago... also provide pap smears, breast and cervical exams, STD testing and treatment, vaccinations for hepatitis A and B, and screenings for hepatitis C and spinal ...

President awards national science and technology medals
NEPA News, PA - Feb 14, 2006... of new blood-testing technologies and systems for the direct detection of viral infections, including West Nile virus, HIV-1 and hepatitis C virus in plasma of ...

Wednesday, February 15, 2006


Hepatitis C Combination Therapy - ARROW THERAPEUTICS SELECTS HEP C CLINICAL CANDIDATE


ARROW THERAPEUTICS SELECTS HEP C CLINICAL CANDIDATE
Asia Pulse via Yahoo! Australia & NZ Finance - Feb 05 11:55 PM
Technology Save to My Web

Teen user hopes for escape from addiction
Bangor Daily News - Feb 09 12:33 AM
Editor's Note: This week's column features a letter we received recently from a young inmate at the Mountain View Youth Development Center in Charleston, a state-run correctional facility for juvenile offenders.Save to My Web

Proposal to give free pipes to crack addicts
The Scotsman: Health - Feb 08 5:15 PM
ADDICTS who smoke crack cocaine could be given free pipes at the taxpayers' expense to prevent the spread of tuberculosis and other diseases.Save to My Web

Speed the Plough
The Motley Fool via Yahoo! News - Jan 30 7:12 AM
If you believe the stories, people who have near-death experiences come away from it all as very different people. That seems to be true for corporations as well; the revived Schering-Plough (NYSE: SGP - News) now seems like very different company.Save to My Web

Hepatitis C Combination Therapy - Pegasys Shown More Effective In Study


Pegasys Shown More Effective In Study
Schering and Roche are taking part in dueling press releases. Each claiming their solution is better. Either way, they seem to be splitting hairs regarding effectiveness. There is no clear winner when they keep firing PR salvos back and forth....

SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Another delay at tainted blood trial
Blink: Hepatitis C Added by mfeed 680 News - There is yet another delay in the tainted blood case in Toronto. The Crown has asked for time to reassess its case in light of new evidence that could exonerate some of the defendants. Defence lawyer Eddie Greenspan says the evidence will exonerate ...... Read more... Discover Cool New Cars

Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

Tuesday, February 14, 2006


Hepatitis C Combination Therapy - Peregrine accelerates Tarvacin development


Peregrine accelerates Tarvacin development
Pharmaceutical Business Review - Jan 19, 2006... Peregrine. In the phase I trial, a single dose of Tarvacin is being tested in patients with chronic hepatitis C infection. Data ...

Mortality falls in HIV/HCV coinfected Spaniards after the ...
Aidsmap, UK - Jan 12, 2006... of death fell by 20% for individuals coinfected with HIV and hepatitis C virus, but increased by 50% for injecting drug users who only had hepatitis C infection ...

COMUNICADO: GlaxoSmithKline Announces Commencement of Eltrombopag ...
Europa Press, Spain - 20 hours ago... It can prevent cancer patients from receiving their full dose of chemotherapy, prevent patients with hepatitis C infection from receiving interferon therapy or ...

Koronis Pharmaceuticals to Participate in Panel 'Infectious ...
PR Newswire (press release), NY - Feb 9, 2006... to the Company's lead product candidate, KP-1461 for AIDS/HIV, the Company has product candidates in development for the treatment of hepatitis C infection. ...

My dad was dying and we never knew
Norfolk Eastern Daily Press, UK - Jan 26, 2006... This include raising awareness of groups that may have been at past risk of hepatitis C infection including recipients of blood transfusion before donor ...

Hepatitis C Combination Therapy - Novartis And Idenix Seek European Approval Of Telbivudine (LDT600) For


Novartis And Idenix Seek European Approval Of Telbivudine (LDT600) For
Medical News Today - Novartis and Idenix Pharmaceuticals, Inc. announced today the European submission of telbivudine (LTD600) for approval as a novel treatment for patients affected by chronic hepatitis B (CHB), a potentially fatal disease estimated to affect more than

Viral Hepatitis and HIV Coinfection
Medscape News - In Western countries, chronic HBV infection affects 5% to 10% of HIV-positive individuals. However, a larger proportion of the HIV-infected population has been exposed to HBV in the past. Isolated hepatitis B core antibody (anti-HBc) is more common

FDA Grants Fast Track Designation To Oral HCV Protease Inhibitor SCH
Medical News Today - Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment

Schering-Plough drug gets fast track
BusinessWeek - JAN. 30 9:44 A.M. ET Drug maker Schering-Plough Corp. said Monday that regulators granted "fast track" status to its experimental hepatitis C treatment. The Food and Drug Administration gives the fast track label -- which sometimes helps speed the

Hepatitis C Combination Therapy - FindArticles search for ""Viral hepatitis""


FindArticles search for ""Viral hepatitis""
... and thioredoxin levels in patients with viral hepatitis C. OBJECTIVES: Oxidative stress induces cellular responses ...

Genotype Research 2004
Genotype Research 2004. Page Two. Effects of ribavirin combined with interferon-alpha2b on viral kinetics during first 12 weeks of treatment in patients with hepatitis C virus genotype 1 and high baseline viral loads"

Glucocorticosteroids for viral hepatitis C (Cochrane Review)
Abstract of a systematic review of the effects of health care prepared by the Cochrane Collaboration ... Randomised clinical trials dealing with glucocorticosteroids for viral hepatitis C - acute or chronic with or without ...

Monday, February 13, 2006


Hepatitis C Combination Therapy - Hep C Boy Inspiration


Hep C Boy Inspiration
hep c ditty, words by MadPaulo music and performance by john_boy, the guys hang out here. I ll bet my bottom dollar that once they get signed to a record deal they won t want to know little Hep C

Methadone Anonymous -- View Forum - HIV / HCV in the News
Marijuana just how bad is it for us with Hep C??? truetildeath13 4 564 Sun Jan 15, 2006 3:39 pm korshoski HIV Tracking System May Be Scrapped Bev 0 278 Tue Jul 26, 2005 10:04 am Bev AIDS Crisis Brings Radical

Hep C Links - Hepatitis C Association
Hep C Advocate Network, Inc. (HepCAN) Hepatitis C Advocacy Hepatitis C Caring Ambassadors: Choices Hepatitis C Coordinators Hepatitis

Hep C - the straight up.
posted by Hep C - the straightup at 7:04 PM 0 comments links to this post About Me Name: Hep C - the straightup i'm pretty nondescript. View my complete profile Links Hep C - the straight up HCV

Peel Gets Hip 2 Hep C - What is hep C? Stats
Stats - The face of hep C In 2000, 444 new cases were diagnosed in Peel Region Health Canada estimates that 210,000 to 275,000 Canadians are infected with hepatitis C, but only 30 per cent of

Sunday, February 12, 2006


Hepatitis C Combination Therapy - Schering-Plough Drug Gets Fast Track


Schering-Plough Drug Gets Fast Track
MSN MoneyCentral - KENILWORTH, N.J. (AP) - Drug maker Schering-Plough Corp. said Monday that regulators granted "fast track" status to its experimental hepatitis C treatment. The Food and Drug Administration gives the fast track label -- which sometimes helps speed the

Novartis And Idenix Seek European Approval Of Telbivudine (LDT600) For
Medical News Today - Novartis and Idenix Pharmaceuticals, Inc. announced today the European submission of telbivudine (LTD600) for approval as a novel treatment for patients affected by chronic hepatitis B (CHB), a potentially fatal disease estimated to affect more than

FDA Grants Fast Track Designation To Oral HCV Protease Inhibitor SCH
Medical News Today - Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment

Viral Hepatitis and HIV Coinfection
Medscape News - In Western countries, chronic HBV infection affects 5% to 10% of HIV-positive individuals. However, a larger proportion of the HIV-infected population has been exposed to HBV in the past. Isolated hepatitis B core antibody (anti-HBc) is more common

Hepatitis C Combination Therapy - Hepatitis C Virus Lives In Your Liver(NC)-Your liver

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>